Credit Suisse’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $110K | Sell |
15,600
-4,400
| -22% | -$31K | ﹤0.01% | 2924 |
|
|
2023
Q4 | $113K | Sell |
20,000
-45,353
| -69% | -$256K | ﹤0.01% | 3014 |
|
|
2023
Q3 | $313K | Buy |
65,353
+11,624
| +22% | +$55.7K | ﹤0.01% | 2911 |
|
|
2023
Q2 | $368K | Buy |
53,729
+20,090
| +60% | +$138K | ﹤0.01% | 2916 |
|
|
2023
Q1 | $262K | Buy |
33,639
+5,766
| +21% | +$44.9K | ﹤0.01% | 3026 |
|
|
2022
Q4 | $212K | Buy |
27,873
+5,660
| +25% | +$43.1K | ﹤0.01% | 3147 |
|
|
2022
Q3 | $181K | Buy |
22,213
+12,136
| +120% | +$98.9K | ﹤0.01% | 3264 |
|
|
2022
Q2 | $98K | Buy |
+10,077
| New | +$98K | ﹤0.01% | 3515 |
|